A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.
Gregory DurmSalma K JabbourSandra K AlthouseZiyue LiuAhad A SadiqRobin T ZonShadia I JalalGoetz H KloeckerMichael J WilliamsonKaren L ReckampRobert M LangdonEbenezer A KioRyan D GentzlerBamidele A AdesunloyeWael A HarbRadhika V WallingMichael L TitzerNasser H HannaPublished in: Cancer (2020)
Consolidation pembrolizumab after concurrent chemoradiation improves TMDD, PFS, and OS in comparison with historical controls of chemoradiation alone. Rates of grade 3 to 5 pneumonitis were similar to those reported with chemoradiation alone.